HEALTH CARE:
BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS
Deciphera Pharmaceuticals, Inc. operates as a biotechnology company. The Company discovers and develops kinase inhibitor treatments for various type of cancer diseases including gastrointestinal, stromal tumors, advance systemic mastocytosis, gliomas, and other solid tumors. Deciphera Pharmaceuticals serves patients globally.
| Market Cap | 712.743 Million | Shares Outstanding | 32.59 Million | Avg Volume | 145.652 Thousand |
| 1-Yr BETA vs S&P TR | 1.853 | Current Ratio | 12.77 | Quick Ratio | 12.77 |
| Q2 2019 | All Institutions | Hedge Funds 1 |
|---|---|---|
| To trade DCPH now: | |
|
| Filers who had this stock in their top 10: | 3 | 2 (0.21%) |
| 13F Filers holding this stock: | 83 | 17 (1.76%) |
| Aggregate 13F shares on 06/30/2019: | 23.133 Million | 15.756 Million |
| Aggregate 13F shares on 03/31/2019: | 22.484 Million | 15.539 Million |
| Percent change: | 2.89% | 1.40% |
| Funds creating new positions: | 16 | 1 |
| Funds Adding to an existing position: | 35 | 8 |
| Funds closing out their position: | 11 | 7 |
| Funds reducing their position: | 17 | 4 |
| 1 hedge funds as identified by whalewisdom.com through public filings. | ||
View recent insider trading info
Deciphera Pharmaceuticals Inc Chart by YCharts
Please sign in first
none
207 Thousand total shares from 15 transactions
182 Thousand total shares from 5 transactions
| Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
|---|---|---|---|---|
|
KELLY THOMAS PATRICK CHIEF FINANCIAL OFFICER |
|
0 | 2019-08-13 | 8 |
|
0 | 2019-08-13 | 5 | |
|
0 | 2019-08-13 | 5 | |
|
FLYNN DANIEL LEE CHIEF SCIENTIFIC OFFICER |
|
146,549 | 2019-08-13 | 4 |
|
0 | 2019-07-08 | 2 | |
|
0 | 2019-06-14 | 0 | |
|
0 | 2019-06-11 | 1 | |
|
0 | 2019-06-11 | 1 | |
|
0 | 2019-06-11 | 1 | |
|
0 | 2019-06-11 | 1 | |
|
0 | 2019-06-11 | 1 | |
|
0 | 2019-06-06 | 1 | |
|
MARTIN DANIEL C. CHIEF COMMERCIAL OFFICER |
|
0 | 2019-01-30 | 3 |
|
RUDDY STEPHEN B. CHIEF TECHNICAL OFFICER |
|
0 | 2019-01-30 | 1 |
|
MORL CHRISTOPHER JOHN CHIEF BUSINESS OFFICER |
|
0 | 2019-01-30 | 1 |
|
NEW LEAF VENTURE MANAGEMENT III, L.L.C. NEW LEAF VENTURE ASSOCIATES III, L.P. |
|
No longer subject to file | 2018-06-25 | 0 |
|
16,572,370 | 2017-10-02 | 0 | |
|
ROSEN OLIVER CHIEF MEDICAL OFFICER |
|
0 | 2017-10-02 | 0 |
| Reporting Owners | Transaction Date | Transaction Code | Shares | Share Price | Acquired or Disposed | Shares Owned Following Transaction | Combined shares owned after filing | Direct/Indirect Ownership | 10b-5 |
|---|---|---|---|---|---|---|---|---|---|
| 2019-08-13 | S | 29,712 | $41.33 | d | 24,500 | 146,549.00 | direct | yes | |
| 2019-08-13 | M | 11,250 | d | 138,008 | 0.00 | direct | |||
| 2019-08-13 | S | 7,264 | $40.69 | d | 3,986 | 0.00 | direct | yes | |
| 2019-08-13 | S | 4,000 | $42.49 | d | 0 | 0.00 | direct | yes | |
| 2019-08-13 | S | 3,433 | $39.47 | d | 19,067 | 0.00 | direct | yes | |
| 2019-08-13 | S | 100 | $42.90 | d | 0 | 0.00 | direct | yes | |
| 2019-08-13 | S | 11,513 | $39.24 | d | 13,487 | 0.00 | direct | yes | |
| 2019-08-13 | M | 123,107 | d | 349,571 | 146,549.00 | direct | |||
| 2019-08-13 | S | 93,395 | $40.26 | d | 54,212 | 146,549.00 | direct | yes | |
| 2019-08-13 | S | 400 | $42.92 | d | 0 | 0.00 | direct | yes | |
| 2019-08-13 | M | 11,250 | $1.89 | a | 11,250 | 0.00 | direct | ||
| 2019-08-13 | S | 1,300 | $41.77 | d | 4,000 | 0.00 | direct | yes | |
| 2019-08-13 | M | 22,500 | $1.89 | a | 22,500 | 0.00 | direct | ||
| 2019-08-13 | S | 700 | $42.05 | d | 100 | 0.00 | direct | yes | |
| 2019-08-13 | M | 25,000 | $1.89 | a | 25,000 | 0.00 | direct | ||
|
FLYNN DANIEL LEE - Officer CHIEF SCIENTIFIC OFFICER by daniel l. flynn irrevocable trust |
2019-08-13 | S | 25,000 | $42.90 | d | 66,779 | 146,549.00 | indirect | yes |
| 2019-08-13 | M | 123,107 | $1.89 | a | 147,607 | 146,549.00 | direct | ||
| 2019-08-13 | S | 3,586 | $42.25 | d | 400 | 0.00 | direct | yes | |
| 2019-08-13 | M | 22,500 | d | 517,135 | 0.00 | direct | |||
| 2019-08-13 | S | 13,767 | $40.50 | d | 5,300 | 0.00 | direct | yes | |
| 2019-08-13 | M | 25,000 | d | 88,408 | 0.00 | direct | |||
| 2019-08-13 | S | 12,687 | $40.50 | d | 800 | 0.00 | direct | yes | |
| 2019-07-08 | A | 24,000 | a | 24,000 | 0.00 | direct | |||
| 2019-06-19 | M | 177 | $1.89 | a | 177 | 0.00 | direct | ||
| 2019-06-19 | M | 177 | d | 149,258 | 0.00 | direct | |||
| 2019-06-19 | S | 177 | $25.00 | d | 0 | 0.00 | direct | yes |
